CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
CLOVER HEALTH INVESTMENTS, CORP. /DE
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$4.44−0.04 (-0.89%)
Close on Oct 19, 2026
- Market cap
- $2.42B
- P/E (TTM)
- –
- Dividend yield
- –
CLOVER HEALTH INVESTMENTS, CORP. /DE revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Insurance segment | $64.76M | $55.72M | $49.81M | $36.17M | $32.65M | $3.96M | – | – | – | – | – | – | 2.6% | +98.3% |
| Non-Insurance | – | – | – | – | – | – | – | – | – | – | – | $0 | – | – |
| Insurance Segment | – | – | – | – | – | – | – | – | – | – | – | $3.34M | – | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Clover Health Investments's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.